Abstract
Transforming growth factor (TGF)-β, a pleiotropic cytokine released by both immune and non-immune cells in the gut, exerts an important tolerogenic action by promoting regulatory T cell differentiation. TGF-β also enhances enterocyte migration and regulates extracellular matrix turnover, thereby playing a crucial role in tissue remodeling in the gut. In this review we describe the mechanisms by which abnormal TGF-β signaling impairs intestinal immune tolerance and tissue repair, thus predisposing to the onset of immune-mediated bowel disorders, such as inflammatory bowel disease and celiac disease. Additionally, we will discuss potential therapeutic strategies aiming at restoring physiologic TGF-β signaling in chronic intestinal diseases.
Original language | English |
---|---|
Pages (from-to) | 45-55 |
Number of pages | 11 |
Journal | Cytokine & Growth Factor Reviews |
Volume | 25 |
Issue number | 1 |
Early online date | 28 Nov 2013 |
DOIs | |
Publication status | Published - Feb 2014 |
Keywords
- Animals
- Cell Differentiation/physiology
- Humans
- Immune Tolerance/drug effects
- Inflammatory Bowel Diseases/immunology
- Intestinal Mucosa/immunology
- Intestines/immunology
- Mice
- Signal Transduction/physiology
- T-Lymphocytes, Regulatory/physiology
- Transforming Growth Factor beta/physiology
- Wound Healing